Our institute aimed to develop advanced health care units with multidiscipline that spans the fields of nanotechnology, molecular/cellular level physiology and engineering. The research directions can be divided into the following categories:

1. Tissue Engineering

The so-called "tissue engineering" is a new field of science and technology that applied pioneering multidiscipline methods to fabricate artificial organs for replacing dysfunctional human parts. It covers cytology, physiology, molecular biology, clinical medicine, surgery, pathology and veterinary expertise and utilizes the developed artificial biocompatible implants to promote tissue-remodeling, repair and enhance the organ function.

Our university, as one of the pioneers in this field, formed alliance with physicians and medical staffs in hospitals located in central part of Taiwan and received funds from National Health Research Institute (Taiwan) to establish Tissue Engineering and Stem Cell Research Center in National Chung Hsing University in 2003. Our school invested another 10 million New Taiwan dollors for upgrading in the following 2 years, and eventually resulting in the onset of our institute with the established human and facility resources.

2. Biomedical Instrumentation

Biomedical Instrumentation develops new devices and procedures for solving medical and health-related issues with the advancement of hard and software design, computing technique, and nanomaterials. These instruments covers a wide range of systems from large imaging modalities such as computerized tomography and magnetic resonance imaging, to small implantable devices, such as cochlear implants, pacemakers.

Our institute will emphasize on the development of artificial intelligence and wireless communication for constructing remote sensing and assisting system for the healthcare of senior population to form a healthcare information platform with continuously healthcare monitoring.

3. Biosensor

Biosensing is an analytical tools involving biorecognition and transducing procedures for measuring bioanalytes or evaluating the activity of biological functions. The biorecognition procedure requires a biologically derived material or biomimetic component that interacts, binds, or recognizes the analyte under investigation; while the transducing procedure converting the biorecognized target into a quantifiable/amplifiable parameter for defining the physical or chemical status of the bioanalyte or biological procedure. The development of nanotechonolgy and biochip have improved the performance of conventional biosensing technique.

Our institute have been collaborated with the expertise in hospital, for developing biosensor in food-toxicity screening detection, high sensitivity bacterial infection detection, and towards the early detection, early treatment of diseases in realizing the perspective of preventive medicine for point-of-care applications while fulfilling the criteria of clinical standards.

4. Biomedical Imaging

The molecular and functional imaging are the new targets of medical imaging. Rapid detection of disease and early assessment of drug responses are the main priority of clinical applications.

With the aid of new imaging technologies development, such as fluorescent imaging, near-infrared spectral imaging and single photon emission or multi-photon imaging or development of new contrast agents, it is with potential with sufficient improvement in Rapid detection of disease and early assessment of therapeutic responses.